Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.0013 | 0.5 | 0.5 |
Loa Loa (eye worm) | brahma associated protein | 0.0013 | 0.5 | 0.5 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0013 | 0.5 | 0.5 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.0013 | 0.5 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0013 | 0.5 | 0.5 |
Schistosoma mansoni | brg-1 associated factor | 0.0013 | 0.5 | 0.5 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0013 | 0.5 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0013 | 0.5 | 0.5 |
Brugia malayi | brahma associated protein 60 kDa | 0.0013 | 0.5 | 0.5 |
Chlamydia trachomatis | SWIB complex protein | 0.0013 | 0.5 | 0.5 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0013 | 0.5 | 0.5 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0013 | 0.5 | 0.5 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.0013 | 0.5 | 0.5 |
Onchocerca volvulus | 0.0013 | 0.5 | 0.5 | |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0013 | 0.5 | 0.5 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0013 | 0.5 | 0.5 |
Chlamydia trachomatis | DNA topoisomerase I | 0.0013 | 0.5 | 0.5 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0013 | 0.5 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0013 | 0.5 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0013 | 0.5 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0013 | 0.5 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0013 | 0.5 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0013 | 0.5 | 0.5 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0013 | 0.5 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.